Show simple item record

ARGON PLASMA COAGULATION USE IN PALLIATIVE TREATMENT OF TYPICAL-ATYPICAL CARCINOID TUMORS

dc.contributor.authorZengin, Fatih
dc.contributor.authorDagistanli, Ahmet Serhan
dc.contributor.authorErelel, Mustafa
dc.date.accessioned2021-03-03T16:03:07Z
dc.date.available2021-03-03T16:03:07Z
dc.date.issued2020
dc.identifier.citationErelel M., Dagistanli A. S. , Zengin F., "ARGON PLASMA COAGULATION USE IN PALLIATIVE TREATMENT OF TYPICAL-ATYPICAL CARCINOID TUMORS", NOBEL MEDICUS, cilt.16, sa.1, ss.70-74, 2020
dc.identifier.othervv_1032021
dc.identifier.otherav_42298f08-ccc1-4a6c-ad9e-42f150cd9b39
dc.identifier.urihttp://hdl.handle.net/20.500.12627/48209
dc.description.abstractBronchial carcinoid tumors constitute 1-2% of all primary lung tumors. The main treatment for lung carcinoid tumors is surgery but bronchoscopic endobronchial therapy is also a palliative option for poor surgical candidates. This study will discuss the outcomes of bronchoscopic endobronchial treatment for two cases. Case 1 has a typical carcinoid tumor in right upper lobe and has multiple comorbidities. Case 2 is a patient with metastatic atypical carcinoid tumor who was operated before. We used argon plasma coagulation technique in treatment of both cases.
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectTIP, GENEL & İÇECEK
dc.subjectTemel Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.titleARGON PLASMA COAGULATION USE IN PALLIATIVE TREATMENT OF TYPICAL-ATYPICAL CARCINOID TUMORS
dc.typeMakale
dc.relation.journalNOBEL MEDICUS
dc.contributor.departmentİstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü
dc.identifier.volume16
dc.identifier.issue1
dc.identifier.startpage70
dc.identifier.endpage74
dc.contributor.firstauthorID2276193


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record